Bioharvest Sciences Inc. SEC filings BHST

Bioharvest Sciences Inc. has 136 filings in SEC EDGAR's recent list, going back to Nov 24, 2017. Its latest annual report, Form 40-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.

Bioharvest Sciences Inc. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 29, 2026 Oct 29, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Oct 8, 2026 Oct 8, 2026
6-K Current report (foreign issuer) Oct 2, 2026 Oct 1, 2026
6-K Current report (foreign issuer) Sep 15, 2026 Sep 15, 2026
6-K Current report (foreign issuer) Sep 15, 2026 Sep 15, 2026
6-K Current report (foreign issuer) Sep 14, 2026 Sep 14, 2026
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
6-K Current report (foreign issuer) Aug 12, 2026 Aug 11, 2026
6-K Current report (foreign issuer) Aug 11, 2026 Aug 11, 2026
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
6-K Current report (foreign issuer) Jul 28, 2026 Jul 28, 2026
6-K Current report (foreign issuer) Jul 16, 2026 Jul 15, 2026
6-K Current report (foreign issuer) Jul 15, 2026 Jul 15, 2026
6-K Current report (foreign issuer) Jun 18, 2026 Jun 18, 2026
6-K Current report (foreign issuer) May 28, 2026 May 27, 2026
6-K Current report (foreign issuer) May 14, 2026 May 14, 2026
6-K Current report (foreign issuer) May 14, 2026 Mar 31, 2026
6-K Current report (foreign issuer) May 14, 2026 May 12, 2026
6-K Current report (foreign issuer) May 13, 2026 May 13, 2026
6-K Current report (foreign issuer) May 12, 2026 May 12, 2026
6-K Current report (foreign issuer) May 11, 2026 May 11, 2026
6-K Current report (foreign issuer) May 1, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
40-F Annual report (Canadian issuer) Mar 31, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 27, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 17, 2026 Mar 17, 2026
6-K Current report (foreign issuer) Mar 16, 2026 Mar 13, 2026
6-K Current report (foreign issuer) Mar 6, 2026 Mar 6, 2026
6-K Current report (foreign issuer) Mar 5, 2026 Mar 5, 2026
6-K Current report (foreign issuer) Mar 3, 2026 Mar 3, 2026
6-K Current report (foreign issuer) Jan 7, 2026 Jan 7, 2026
AW Amendment withdrawal request for pos am Dec 31, 2025 —
POS AM Post-effective amendment no. 1 to form f-3 Dec 29, 2025 —
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Dec 3, 2025 Dec 3, 2025
6-K Current report (foreign issuer) Nov 13, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Nov 12, 2025 Nov 12, 2025
6-K Current report (foreign issuer) Nov 10, 2025 Nov 10, 2025
6-K Current report (foreign issuer) Nov 10, 2025 Nov 7, 2025
424B5 Prospectus supplement Nov 10, 2025 —
424B7 Prospectus supplement no. 3 Nov 6, 2025 —
6-K Current report (foreign issuer) Nov 4, 2025 Nov 4, 2025
6-K Current report (foreign issuer) Oct 31, 2025 Oct 31, 2025
6-K Current report (foreign issuer) Oct 31, 2025 Oct 30, 2025
424B7 Prospectus supplement no. 2 Oct 15, 2025 —
D Filing Oct 6, 2025 —
424B7 Prospectus supplement no. 1 Sep 24, 2025 —
6-K Current report (foreign issuer) Sep 23, 2025 Sep 23, 2025
6-K Current report (foreign issuer) Sep 22, 2025 Sep 22, 2025
6-K Current report (foreign issuer) Sep 10, 2025 Sep 10, 2025
6-K Current report (foreign issuer) Sep 9, 2025 Sep 9, 2025
6-K Current report (foreign issuer) Sep 9, 2025 Sep 8, 2025
EFFECT Filing Sep 8, 2025 —
CORRESP Letter to the SEC Sep 4, 2025 —
UPLOAD Letter from the SEC Sep 3, 2025 —
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
DEL AM Delaying amendment Aug 28, 2025 —
F-3 Shelf registration (foreign issuer) Aug 28, 2025 —
6-K Current report (foreign issuer) Aug 15, 2025 Aug 14, 2025
6-K Current report (foreign issuer) Aug 13, 2025 Aug 13, 2025
6-K Current report (foreign issuer) Aug 11, 2025 Aug 11, 2025
6-K Current report (foreign issuer) Aug 11, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Aug 5, 2025 Aug 4, 2025
6-K Current report (foreign issuer) Jul 23, 2025 Jul 23, 2025
S-8 Employee stock plan registration Jul 23, 2025 —
6-K Current report (foreign issuer) Jul 7, 2025 Jul 4, 2025
6-K Current report (foreign issuer) Jul 3, 2025 Jul 2, 2025
6-K Current report (foreign issuer) Jun 10, 2025 Jun 9, 2025
6-K Current report (foreign issuer) Jun 4, 2025 Jun 4, 2025
6-K Current report (foreign issuer) May 21, 2025 May 21, 2025
6-K Current report (foreign issuer) May 15, 2025 May 15, 2025
6-K Current report (foreign issuer) May 15, 2025 Mar 31, 2025
6-K Current report (foreign issuer) May 12, 2025 May 12, 2025
6-K Current report (foreign issuer) May 1, 2025 May 1, 2025
6-K Current report (foreign issuer) Apr 1, 2025 Mar 31, 2025
6-K Current report (foreign issuer) Apr 1, 2025 Mar 31, 2025
F-X Appointment of agent for service of process and undertaking Mar 31, 2025 —
40-F Annual report (Canadian issuer) Mar 31, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 17, 2025 Mar 17, 2025
6-K Current report (foreign issuer) Mar 6, 2025 Mar 6, 2025
6-K Current report (foreign issuer) Mar 4, 2025 Mar 4, 2025
6-K Current report (foreign issuer) Feb 18, 2025 Feb 18, 2025
6-K Current report (foreign issuer) Feb 14, 2025 Feb 14, 2025
6-K Current report (foreign issuer) Feb 12, 2025 Feb 12, 2025
6-K Current report (foreign issuer) Feb 11, 2025 Feb 10, 2025
6-K Current report (foreign issuer) Jan 23, 2025 Jan 16, 2025
6-K Current report (foreign issuer) Jan 22, 2025 Jan 22, 2025
6-K Current report (foreign issuer) Jan 8, 2025 Jan 8, 2025
6-K Current report (foreign issuer) Dec 11, 2024 Dec 11, 2024
6-K Current report (foreign issuer) Nov 26, 2024 Nov 25, 2024
6-K Current report (foreign issuer) Nov 25, 2024 Nov 25, 2024
6-K Current report (foreign issuer) Nov 25, 2024 Sep 30, 2024
6-K Current report (foreign issuer) Nov 21, 2024 Nov 21, 2024
6-K Current report (foreign issuer) Nov 19, 2024 Nov 18, 2024
6-K Current report (foreign issuer) Nov 18, 2024 Nov 15, 2024
6-K Current report (foreign issuer) Nov 12, 2024 Nov 12, 2024
CERT Filing Nov 8, 2024 —
CERT Filing Nov 8, 2024 —
6-K Current report (foreign issuer) Nov 8, 2024 Nov 7, 2024
6-K Current report (foreign issuer) Oct 29, 2024 Oct 28, 2024
6-K Current report (foreign issuer) Oct 28, 2024 Oct 28, 2024
8-A12B Registration statement Oct 28, 2024 —
6-K Current report (foreign issuer) Oct 23, 2024 Oct 23, 2024
6-K Current report (foreign issuer) Oct 16, 2024 Oct 16, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
6-K Current report (foreign issuer) Sep 12, 2024 Sep 12, 2024
6-K Current report (foreign issuer) Sep 6, 2024 Sep 5, 2024
6-K Current report (foreign issuer) Sep 5, 2024 Sep 4, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 28, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Jun 30, 2024
SEC STAFF LETTER Filing Aug 27, 2024 —
UPLOAD Letter from the SEC Aug 27, 2024 —
20FR12G/A Registration statement Aug 22, 2024 —
UPLOAD Letter from the SEC Aug 21, 2024 —
20FR12G/A Registration statement Aug 14, 2024 —
UPLOAD Letter from the SEC Aug 6, 2024 —
20FR12G/A Registration statement Jul 24, 2024 —
SEC STAFF LETTER Filing Jul 12, 2024 —
UPLOAD Letter from the SEC Jul 10, 2024 —
20FR12G Registration statement Jun 14, 2024 —
D Filing Jan 11, 2024 —
D Filing Nov 21, 2023 —
D Filing Aug 10, 2023 —
D Filing Oct 25, 2022 —
D Filing Sep 13, 2021 —
D Filing Feb 17, 2021 —
D Filing Sep 29, 2020 —
D Filing Aug 13, 2020 —
D Filing Apr 21, 2020 —
D Filing Oct 8, 2019 —
D/A Filing Oct 15, 2018 —
D Filing Oct 15, 2018 —
D Filing Nov 24, 2017 —

Showing 135 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BHST (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Vancouver, British Columbia, Canada
SEC filer status
, Emerging growth company
SEC CIK
1723464
Former names
CANNA-V-CELL SCIENCES INC. (until Apr 21, 2020); Midnight Star Ventures Corp. (until Oct 15, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.